Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 09:00 ET | Source: Biofrontera Inc.

Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities

Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz® over treatment area of 240 cm2Completion of this study marks a key milestone...
December 03, 2025 08:00 ET | Source: Beauty Innovation Awards

Saranghae Advanced Brightening Dark Spot Repair Serum Named “Anti-Blemish Product of the Year” By Beauty Innovation

LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The 2025 Beauty Innovation Awards today announced K-beauty brand Saranghae’s Advanced Brightening Dark Spot Repair Serum has been selected as...
December 02, 2025 08:45 ET | Source: Biofrontera Inc.

Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT

sNDA for treatment of sBCC with Ameluz®-PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025First Phase 3 PDT study in patients with sBCC in the United States submitted to...
November 26, 2025 08:45 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

THE WOODLANDS, TX, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
October 22, 2025 10:07 ET | Source: Nkarta, Inc.

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to...
October 22, 2025 09:25 ET | Source: Neurologic Wellness Institute

What is Dysautonomia? Experts Explain Warning Signs During Awareness Month

Chicago, IL, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Do you experience unexplained dizziness when standing, chronic fatigue that doctors can’t explain, or a racing heart for no apparent reason? You might...
October 14, 2025 08:20 ET | Source: Imunon, Inc.

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway Company on...
October 09, 2025 10:01 ET | Source: Optime Care

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
October 01, 2025 08:00 ET | Source: ATMA CENA

ATMA CENA Grows National Mental Health Network to 13 Clinics

ATMA CENA announce the expansion of its psychedelic therapy clinic network to 13 locations across Canada
September 19, 2025 15:40 ET | Source: Tevogen Bio Inc

Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans

WARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its gratitude to the U.S. Department of Health and Human Services...